Sciatica – Back Care (Newton Laboratories, Inc.)
Welcome to the PulseAid listing for the Sciatica – Back Care drug offered from Newton Laboratories, Inc.. This Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Mood Stabilizer [EPC],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Newton Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Aconitum nap., Ammonium benzoicum, Arsenicum alb., Benzoicum acidum, Bryonia, Causticum, Cinchona, Colchicum, Gnaphalium polycephalum, Iris versicolor, Kali iod., Ledum, Lithium carb., Nux vom., Phyto |
| SUBSTANCE NAME: | ACONITUM NAPELLUS; AMMONIUM BENZOATE; ARSENIC TRIOXIDE; BENZOIC ACID; BRYONIA ALBA ROOT; CAUSTICUM; CINCHONA OFFICINALIS BARK; PSEUDOGNAPHALIUM OBTUSIFOLIUM; IRIS VERSICOLOR ROOT; POTASSIUM IODIDE; LE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Mood Stabilizer [EPC],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | PELLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
Sciatica – Back Care HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sciatica – Back Care from Newton Laboratories, Inc. |
| LABELER NAME: | Newton Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 20; 8; 8; 20([hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; ) |
| START MARKETING DATE: | 2011-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55714-4481_78b98f9c-a0c4-8ad3-e14c-d5dce417723a |
| PRODUCT NDC: | 55714-4481 |
| APPLICATION NUMBER: | |
Other ACONITUM NAPELLUS; AMMONIUM BENZOATE; ARSENIC TRIOXIDE; BENZOIC ACID; BRYONIA ALBA ROOT; CAUSTICUM; CINCHONA OFFICINALIS BARK; PSEUDOGNAPHALIUM OBTUSIFOLIUM; IRIS VERSICOLOR ROOT; POTASSIUM IODIDE; LE Pharmaceutical Manufacturers / Labelers:
